Clinical Trial Update: Protandim and the Metabolic Syndrome [NA]

View source ↗

Summary

The clinical trial NCT01125501 evaluating Protandim for metabolic syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Protandim

Snippet

Sponsor: SomaLogic, Inc. | Conditions: Metabolic Syndrome | NA | Status: WITHDRAWN